Brand Intelligence Graphcompany
Company Overview
About Zoetis
Zoetis Inc. is the world's largest animal health company, developing, manufacturing, and commercializing medicines, vaccines, diagnostics, and other technologies for companion animals (dogs, cats, horses) and livestock (cattle, swine, poultry, fish). Spun off from Pfizer in 2013, Zoetis has maintained its position as the global leader in animal health with approximately 300 product lines serving veterinarians, livestock producers, and pet owners in over 100 countries.
Business Model & Competitive Advantage
Zoetis reported approximately $9.1 billion in revenue in FY2024, with companion animals representing roughly 55% of revenue and growing faster than the livestock segment. The shift toward companion animals reflects a powerful cultural and demographic trend: pet ownership is increasing globally, pets are increasingly viewed as family members, and spending per pet is rising as veterinary capabilities advance and pet insurance adoption grows. Zoetis's blockbuster portfolio includes Apoquel and Cytopoint (atopic dermatitis treatments for dogs), Simparica Trio (parasite protection), and Librela/Solensia (monoclonal antibodies for osteoarthritis pain in dogs and cats).
Competitive Landscape 2025–2026
The monoclonal antibody franchise represents Zoetis's most significant innovation: Librela (bedinvetmab) is the first approved monoclonal antibody for pain management in dogs with osteoarthritis, addressing an enormous unmet need in companion animals. These biologics are protected by complex manufacturing processes and intellectual property, creating durable competitive advantages. The livestock segment provides steady cash flows from parasiticides, antibiotics, and vaccines, while the companion animal segment drives premium growth through innovative specialty products.
Recent Activity
View all →Key Differentiators
Market Leader
Zoetis is recognized as a market leader in the Healthcare Tech sector, demonstrating strong industry presence and customer trust.
Enterprise Scale
With $9.1B in revenue, Zoetis operates at enterprise scale with proven market validation.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Pfizer
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The compan
Moderna
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stép
Amgen
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologic
Veeva Systems
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv
Doximity
Doximity is a professional network and digital health platform purpose-built for licensed physicians and other healthcare professionals in the United States. With more than two million verified clinic
Zocdoc
Zocdoc operates a two-sided marketplace connecting patients with physicians, dentists, and mental health providers who accept their specific insurance and have real-time appointment availability. Pati
Compare Zoetis with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Zoetis? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Zoetis Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Zoetis vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →